Landmarking for Left‐Truncated Competing Risk Data
Biometrical Journal · 2024-12 · 66 (8)
DOI: 10.1002/bimj.202400083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biometrical Journal, online erschienen am 29.10.2024. Verfasst von Theresa Unseld und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biometry and Epidemiology, Ulm University, Helmholtzstraße 22, Ulm, Germany. Hauptthemen laut MEDLINE: Fluoroquinolones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Landmarking is an alternative to complex multistate models when the aim is to calculate dynamic predictions. We develop the concept of landmarking for the case of left truncation and competing risks from the application background of drug safety assessment in pregnancy. The method is illustrated with a cohort study of the German Embryotox Pharmacovigilance Institute in Berlin to assess if the risk or the cumulative incidence of adverse pregnancy outcomes, like spontaneous abortions (SABs), is increased in fluoroquinolone‐exposed women. Furthermore, we conduct an extensive simulation study to compare the dynamic predictions and coefficient estimates obtained by landmarking to those from nonparametric multistate models and classical time‐dependent covariate Cox regression. The results from the simulation study indicate that attenuation of the effects is present in the landmark estimates, also in the complex setting considered here, but the estimates are still close to those from the multistate models. Regarding the Berlin fluoroquinolone data, the fluoroquinolone exposure of a pregnant woman in the first trimester seems to increase her cumulative incidence of elective termination of pregnancy over women never exposed before, but there is no evidence of a significantly increased risk or cumulative incidence in exposed women for SABs. This supports previous results on the same data, which were driven from an analysis without landmarking methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Biometry and Epidemiology, Ulm University, Helmholtzstraße 22, Ulm, Germany.
- Institute of Statistics, Ulm University, Helmholtzstraße 20, Ulm, Germany.
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug…
- Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, Berlin, Germany.
ORCID-Profile: Theresa Unseld, Jan Beyersmann
Zitieren
APA
Unseld, T., Bluhmki, T., Beyersmann, J., Beck, E., Padberg, S., & Stegherr, R. (2024). Landmarking for Left‐Truncated Competing Risk Data. Biometrical Journal, 66(8). https://doi.org/10.1002/bimj.202400083
Vancouver
Unseld T, Bluhmki T, Beyersmann J, Beck E, Padberg S, Stegherr R. Landmarking for Left‐Truncated Competing Risk Data. Biometrical Journal. 2024;66(8). doi:10.1002/bimj.202400083
BibTeX
@article{Unseld2024,
author = {Unseld, Theresa and Bluhmki, Tobias and Beyersmann, Jan and Beck, Evelin and Padberg, Stephanie and Stegherr, Regina},
title = {Landmarking for Left‐Truncated Competing Risk Data},
journal = {Biometrical Journal},
year = {2024},
volume = {66},
number = {8},
doi = {10.1002/bimj.202400083}
}
EUVIMED